Single nucleotide polymorphism genotyping of CYP2C19 using a new automated system

Analytical Biochemistry

Volumn 370, Issue 1, 2007, Pages 121-123

  Matsumoto, Naoko ^a,b   Kakihara, Fumiko ^a,b   Kimura, Sayaka ^a,b   Kurebayashi, Yukari ^a,b   Hirai, Mitsuharu ^c   Yohda, Masafumi ^b   Hasegawa, Setsuo ^a  

^a Sekino Clinical Pharmacology Clinic   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^c ARKRAY Healthcare Pvt Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOMATION;

AUTOMATED SYSTEMS; CYP2C19; GENOTYPING; SINGLE NUCLEOTIDE POLYMORPHISMS;

POLYMORPHISM;

CYTOCHROME P450 2C19; CYTOSINE; GUANINE;

ADULT; ARTICLE; AUTOANALYZER; DNA PURIFICATION; EVALUATION; FEMALE; FLUORESCENCE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; JAPAN; MALE; NORMAL HUMAN; PERFORMANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL DETECTION; SINGLE NUCLEOTIDE POLYMORPHISM; VOLUNTEER;

EID: 34548627747     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.06.006     Document Type: Article

References (15)

1. Evans W.E., and Relling M.V. Pharmacogenomics: Translating functional genomics into rational therapeutics. Science 286 (1999) 487-491
2. Huang S.-M., Goodsaid F., Rahman A., Frueh F., and Lesko L. Application of pharmacogenomics in clinical pharmacology. Toxicol. Mech. Methods 16 (2006) 89-99
3. ® FL-labeled probe or primer. Nucleic Acids Res. 29 (2001) e34
4. Andersson T., Regardh C.G., Lou Y.C., Zhang Y., Dahl M.L., and Bertilsson L. Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects. Pharmacogenetics 2 (1992) 25-31
5. Andersson T., Miners J.O., Veronese M.E., Tassaneeyakul W., Tassaneeyakul W., Meyer U.A., and Birkett D.J. Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism. Br. J. Clin. Pharmacol. 36 (1993) 521-530
6. Ishizaki T., and Horai Y. Review article: Cytochrome P450 and the metabolism of proton pump inhibitors-Emphasis on rabeprazole. Aliment. Pharmacol. Ther. 13 suppl. 3 (1999) 27-36
7. Furuta T., Ohashi K., Kamata T., Takashima M., Kosuge K., Kawasaki T., Hanai H., Kubota T., Ishizaki T., and Kaneko E. Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer. Ann. Intern. Med. 129 (1998) 1027-1030
8. Furuta T., Ohashi K., Kosuge K., Zhao X.J., Takashima M., Kimura M., Nishimoto M., Hanai H., Kaneko E., and Ishizaki T. CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans. Clin. Pharmacol. Ther. 65 (1999) 552-561
9. Takakubo F., Kuwano A., and Kondo I. Evidence that poor metabolizers of (S)-mephenytoin could be identified by haplotypes of CYP2C19 in Japanese. Pharmacogenetics 6 (1996) 265-267
10. Kimura M., Ieiri I., Mamiya K., Urae A., and Higuchi S. Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population. Ther. Drug Monit. 20 (1998) 243-247
11. Kubota T., Hibi N., and Chiba K. Linkage of mutant alleles of CYP2C18 and CYP2C19 in a Japanese population. Biochem. Pharmacol. 55 (1998) 2039-2042
12. Yamada S., Onda M., Kato S., Matsuda N., Matsuhisa T., Yamada N., Miki M., and Matsukura N. Genetic differences in CYP2C19 single nucleotide polymorphisms among four Asian populations. J. Gastroenterol. 36 (2001) 669-672
13. Ogawa K., Suno M., Shimizu K., Yoshida M., Awaya T., Matsubara K., and Shiono H. Genotyping of cytochrome p450 isoform genes is useful for forensic identification of cadaver. Leg. Med. (Tokyo) 5 (2003) 132-138
14. Ishiguro A., Kubota T., Soya Y., Sasaki H., Yagyu O., Takarada Y., and Iga T. High-throughput detection of multiple genetic polymorphisms influencing drug metabolism with mismatch primers in allele-specific polymerase chain reaction. Anal. Biochem. 337 (2005) 256-261
15. Fu L.Q., Huang F., Wu D.Z., and Guo J.H. Comparison of genetic polymorphism of cytochrome CYP2C19 between men and women in Chinese population. Acta Pharmaceut. Sin. 39 (2004) 161-163